Literature DB >> 18759997

Post-fracture management of patients with hip fracture: a perspective.

O Bruyere1, M-L Brandi, N Burlet, N Harvey, G Lyritis, H Minne, S Boonen, J-Y Reginster, R Rizzoli, K Akesson.   

Abstract

BACKGROUND: Hip fracture creates a worldwide morbidity, mortality and economic burden. After surgery, many patients experience long-term disability or die as a consequence of the fracture. A fracture is a major risk factor for a subsequent fracture, which may occur within a short interval.
METHODS: A literature search on post-fracture management of patients with hip fracture was performed on the Medline database. Key experts convened to develop a consensus document.
FINDINGS: Management of hip-fracture patients to optimize outcome after hospital discharge requires several stages of care co-ordinated by a multidisciplinary team from before admission through to discharge. Further studies that specifically assess prevention and post-fracture management of hip fracture are needed, as only one study to date has assessed an osteoporosis medication in patients with a recent hip fracture. Proper nutrition is vital to assist bone repair and prevent further falls, particularly in malnourished patients. Vitamin D, calcium and protein supplementation is associated with an increase in hip BMD and reduction in falls. Rehabilitation is essential to improve functional disabilities and survival rates. Fall prevention and functional recovery strategies should include patient education and training to improve balance and increase muscle strength and mobility. Appropriate management can prevent further fractures and it is critical that high-risk patients are identified and treated. To foster this process, clinical pathways have been established to support orthopaedic surgeons.
CONCLUSION: Although hip fracture is generally associated with poor outcomes, appropriate management can ensure optimal recovery and survival, and should be prioritized after a hip fracture to avoid deterioration of health and prevent subsequent fracture.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18759997     DOI: 10.1185/03007990802381430

Source DB:  PubMed          Journal:  Curr Med Res Opin        ISSN: 0300-7995            Impact factor:   2.580


  12 in total

1.  Short-term and long-term orthopaedic issues in patients with fragility fractures.

Authors:  Susan V Bukata; Stephen L Kates; Regis J O'Keefe
Journal:  Clin Orthop Relat Res       Date:  2011-08       Impact factor: 4.176

Review 2.  What rate of utilization is appropriate in musculoskeletal care?

Authors:  Jon D Lurie; John Erik Bell; Jim Weinstein
Journal:  Clin Orthop Relat Res       Date:  2009-05-19       Impact factor: 4.176

3.  Increased incident hip fractures in postmenopausal women with moderate to severe pelvic organ prolapse.

Authors:  Lubna Pal; Susan M Hailpern; Nanette F Santoro; Ruth Freeman; David Barad; Simon Kipersztok; Vanessa M Barnabei; Sylvia Wassertheil-Smoller
Journal:  Menopause       Date:  2011-09       Impact factor: 2.953

4.  The effects of combined human parathyroid hormone (1-34) and simvastatin treatment on the interface of hydroxyapatite-coated titanium rods implanted into osteopenic rats femurs.

Authors:  Zhou-Shan Tao; Wan-Shu Zhou; Bing-li Bai; Wei Cui; Yang-Xun Lv; Xian-Bin Yu; Zheng-Liang Huang; Kai-kai Tu; Qiang Zhou; Tao Sun; Hang Li; Lei Yang
Journal:  J Mater Sci Mater Med       Date:  2016-01-12       Impact factor: 3.896

5.  The T.A.R.Ge.T. project: a regional program to reduce hip fracture in elderly patients. Main results of retrospective phase.

Authors:  Simone Parri; Luisella Cianferotti; Gemma Marcucci; Giorgio Gronchi; Carla Rizzuti; Emanuela Colli; Beatrice Manetti; Walter Naldoni; Maria Luisa Brandi
Journal:  Clin Cases Miner Bone Metab       Date:  2015 Jan-Apr

6.  Vitamin D supplementation in fractured patient: how, when and why.

Authors:  Giovanni Iolascon; G Di Pietro; F Gimigliano
Journal:  Clin Cases Miner Bone Metab       Date:  2009-05

Review 7.  Management of osteoporosis in patients hospitalized for hip fractures.

Authors:  T P Ip; J Leung; A W C Kung
Journal:  Osteoporos Int       Date:  2010-11-06       Impact factor: 4.507

8.  PTH improves titanium implant fixation more than pamidronate or renutrition in osteopenic rats chronically fed a low protein diet.

Authors:  R Dayer; T C Brennan; R Rizzoli; P Ammann
Journal:  Osteoporos Int       Date:  2009-10-27       Impact factor: 4.507

Review 9.  Once-yearly zoledronic acid in hip fracture prevention.

Authors:  Oddom Demontiero; Gustavo Duque
Journal:  Clin Interv Aging       Date:  2009-05-14       Impact factor: 4.458

10.  Patients Undergoing Surgery for Hip Fractures Suffer from Severe Oxidative Stress as Compared to Patients with Hip Osteoarthritis Undergoing Total Hip Arthroplasty.

Authors:  Theofilos Karachalios; Dionyssios Paridis; Fotios Tekos; Zoi Skaperda; Aristidis S Veskoukis; Demetrios Kouretas
Journal:  Oxid Med Cell Longev       Date:  2021-06-09       Impact factor: 6.543

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.